One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Figure 1

Changes in mean best corrected visual acuity (BCVA). Visual acuity was expressed as the logarithm of minimal angle of resolution (logMAR). (a) Mean BCVA of all 38 patients in three GLD groups; GLD ≦ 1800 μm, GLD between 1801 and 3500 μm, and GLD between 3501 and 5400 μm. The group of greatest linear dimension (GLD) ≦ 1800 μm showed better BCVA than those of the other 2 groups at all time points. However, there was no significant different among the 3 groups (𝑃>0.05). (b) Mean BCVA of typical AMD of 24 patients in three GLD groups. (c) Mean BCVA of PCV of 14 patients in 3 GLD groups. Bars indicate standard deviations. *𝑃<0.05, **𝑃<0.01; 𝑃 value for comparison between baseline and each visit. AMD: age-related macular degeneration, PCV: polypoidal choroidal vasculopathy.

(a)

(b)

(c)